Ivan D. Horak
2010
In 2010, Ivan D. Horak earned a total compensation of $1M as Former President, Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,099 |
|---|---|
| Salary | $533,663 |
| Stock Awards | $326,010 |
| Other | $27,580 |
| Total | $1,047,352 |
Horak received $533.7K in salary, accounting for 51% of the total pay in 2010.
Horak also received $160.1K in non-equity incentive plan, $326K in stock awards and $27.6K in other compensation.
Rankings
In 2010, Ivan D. Horak's compensation ranked 5,123rd out of 10,439 executives tracked by ExecPay. In other words, Horak earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,123 out of 10,439 | 51st |
Division Manufacturing | 1,837 out of 3,838 | 52nd |
Major group Chemicals And Allied Products | 379 out of 921 | 59th |
Industry group Drugs | 225 out of 680 | 67th |
Industry Biological Products, Except Diagnostic Substances | 42 out of 142 | 70th |
Source: SEC filing on April 8, 2011.
Horak's colleagues
We found five more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2010.
2010
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2010
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2010
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2010
Mark Ogden
Enzon Pharmaceuticals
Acting Vice President, Finance and Principal Financial Officer
2010
Craig Tooman
Enzon Pharmaceuticals